User,Creation_Date,feedback_txt_re,compound,sentiment,Title_1,Title_2
CuraScriptSD,2020-10-22,news ademaciclib reduces risk invasive breast cancer,-0.7579,negative,news,risk
OncologyNewsAus,2020-10-06,oncology news update esmo year research breakthrough offers hope breast cancer patients been published oncology news australia,-0.3612,negative,news,risk
PracUpOnc,2020-10-03,esmo abemaciclib improves invasive disease free survival reduces risk metastasis high risk hormone receptor positive negative breast cancer,-0.3818,negative,news,risk
mattotcha,2020-10-03,innate immune response produces phenomenal breast cancer control there another really important study from science weekend esmo that want make sure because fear might overlooked,-0.4228,negative,news,risk
OncologyNewsAus,2020-09-22,oncology news update esmo research breakthrough offers hope high risk patients with breast cancer been published oncology news australia,-0.5574,negative,news,risk
OncologyNewsAus,2020-09-21,oncology news update esmo first drug years reduces recurrence high risk hormone receptor positive early breast cancer been published oncology news australia,-0.4404,negative,news,risk
professorSteph7,2020-09-21,many thanks patients investigators trial sponsor involved monarche adjuvant breast cancer trial presented these exciting results those with high risk hormone receptor positive early impressive digital meeting,0.7579,positive,news,risk
naturopathiconc,2020-09-18,stratification risk recurrence with mammoprint also factor esmo data most women have mammoprint done nejm data showing risk grade your graphs early cancer over years much more robust practical,-0.7102,negative,news,risk
demattosarruda,2020-08-18,mutation inhibition hormone receptor positive breast cancer time come editorial just,-0.5106,negative,news,risk
MehrpouyaMobin,2020-10-07,very interesting data from esmo digested brought into clinical context,0.4576,positive,news,risk
charlesryanmd,2020-09-13,congrats many more come showing that patients during therapy experience shorter rpfs only rpfs nsclc effect,0.5267,positive,news,risk
ej23ny,2020-08-20,exel very exciting show case asset data next generation oral tyrosine kinase cabo will born checkmate data phase cosmic second half probably august beginning september,0.7178,positive,news,risk
ej23ny,2020-08-11,exel cosmic readout very soon sept checkmate full data release esmo late breaking abstracts released sept,0.0,neutral,news,risk
iambellat,2020-10-21,happy clinical case presentor virtual esmo preceptorship breast cancer,-0.1779,negative,esmo,cancer
BCTrialsANZ,2020-10-15,this year esmo conference went online with researchers logging over world share their research have provided summary breast cancer research presented this year event,-0.4939,negative,esmo,cancer
orniti,2020-10-14,exploratory analysis circulating cytokines patients with metastatic breast cancer treated with eribulin transeri gono gruppo oncologico nord ovest study just published,-0.6597,negative,esmo,cancer
filimasini,2020-10-03,application esmo magnitude clinical benefit scale field early breast cancer therapies,-0.34,negative,esmo,cancer
PracUpOnc,2020-10-01,esmo recommendations from reshma mahtani breast cancer,-0.6597,negative,esmo,cancer
PracUpOnc,2020-10-01,esmo recommendations from reshma mahtani breast cancer,-0.6597,negative,esmo,cancer
PracUpOnc,2020-10-01,esmo recommendations from prof lillie shockney metastatic breast cancer,-0.6597,negative,esmo,cancer
PracUpOnc,2020-09-30,esmo recommendations from prof lillie shockney metastatic breast cancer,-0.6597,negative,esmo,cancer
drtarsh,2020-09-28,very helpful summary trials using targeted therapy breast cancer from esmo,-0.3197,negative,esmo,cancer
talatmukhtar,2020-09-25,adjuvant palbociclib stage breast cancer research esmo erica mayer,-0.6597,negative,esmo,cancer
boobstagramm,2020-09-24,esmo lilly verzenio pressures pfizer with practice changing early breast cancer fiercepharma,-0.7717,negative,esmo,cancer
Nfcanavan,2020-09-23,hosting esmo wrap friday with bloomberg intelligence topics breast cancer lung cancer kols hope rugo ucsf vamsi velcheti wainberg ucla,-0.5859,negative,esmo,cancer
JAFB1291,2020-09-22,early breast cancer esmo clinical practice guidelines diagnosis treatment follow,-0.6597,negative,esmo,cancer
outcomes4me,2020-09-22,missed esmo congress worries wrap with major takeaways breast cancer patients,-0.8555,negative,esmo,cancer
Pushpita_deb,2020-09-22,esmo verzenio maybe ibrance early stage breast cancer,-0.6597,negative,esmo,cancer
BioWorld,2020-09-22,esmo verzenio maybe ibrance early stage breast cancer,-0.6597,negative,esmo,cancer
Lampgen_CR,2020-09-22,esmo pfizer ibrance flop early breast cancer shouldn hurt metastatic sales exec says fiercepharma,-0.8807,negative,esmo,cancer
AlcuriaRudolph,2020-09-21,esmo lilly verzenio pressures pfizer with practice changing early breast cancer fiercepharma,-0.7717,negative,esmo,cancer
AlcuriaRudolph,2020-09-21,esmo lilly verzenio pressures pfizer with practice changing early breast cancer fiercepharma,-0.7717,negative,esmo,cancer
NewExpressNews,2020-09-21,esmo lilly verzenio pressures pfizer with practice changing early breast cancer,-0.7717,negative,esmo,cancer
HelixBioPharma,2020-09-21,esmo lilly verzenio pressures pfizer with practice changing early breast cancer,-0.7717,negative,esmo,cancer
PharmaNews,2020-09-21,esmo lilly verzenio pressures pfizer with practice changing early breast cancer,-0.7717,negative,esmo,cancer
howtobeatcancer,2020-09-21,esmo pfizer ibrance flop early breast cancer shouldn hurt metastatic sales exec says fiercepharma,-0.8807,negative,esmo,cancer
cafepharma,2020-09-21,esmo lilly verzenio pressures pfizer with practice changing early breast cancer,-0.7717,negative,esmo,cancer
patriciaclarkmd,2020-09-21,reduction recurrence metastasis high risk early breast cancer lilly verzenio pressures pfizer with practice changing early fiercepharma,-0.8316,negative,esmo,cancer
MarcJacksonLA,2020-09-21,esmo lilly verzenio pressures pfizer with practice changing early breast cancer,-0.7717,negative,esmo,cancer
RxDataScience,2020-09-20,esmo lilly verzenio pressures pfizer with practice changing early breast cancer,-0.7717,negative,esmo,cancer
analystlandnews,2020-09-20,esmo lilly verzenio pressures pfizer with practice changing early breast cancer,-0.7717,negative,esmo,cancer
seigomaeda,2020-09-20,esmo lilly verzenio pressures pfizer with practice changing early breast cancer,-0.7717,negative,esmo,cancer
aspenbio,2020-09-19,esmo pfizer ibrance flop early breast cancer shouldn hurt metastatic sales exec says,-0.8807,negative,esmo,cancer
pharm2market,2020-09-19,esmo pfizer ibrance flop early breast cancer shouldn hurt metastatic sales exec says,-0.8807,negative,esmo,cancer
boobstagramm,2020-09-19,esmo pfizer ibrance flop early breast cancer shouldn hurt metastatic sales exec says fiercepharma,-0.8807,negative,esmo,cancer
Conti_Clinical,2020-09-19,esmo pfizer ibrance flop early breast cancer shouldn hurt metastatic sales exec says,-0.8807,negative,esmo,cancer
MarcJacksonLA,2020-09-19,esmo pfizer ibrance flop early breast cancer shouldn hurt metastatic sales exec says,-0.8807,negative,esmo,cancer
mednetnews,2020-09-19,esmo pfizer ibrance flop early breast cancer shouldn hurt metastatic sales exec says,-0.8807,negative,esmo,cancer
seigomaeda,2020-09-19,esmo pfizer ibrance flop early breast cancer shouldn hurt metastatic sales exec says,-0.8807,negative,esmo,cancer
VriesElisabeth,2020-09-07,papers podcast which apply esmo magnitude clinical benefit scale field early breast cancer therapies adjuvant colon cancer trials,-0.7783,negative,esmo,cancer
kevlitchfield,2020-09-21,congratulations excellent esmo oral talk spatial evolution renal tracerx here print this study huge thanks labs clinical teams contributing this study across crick royal marsden guys cruces,0.9153,positive,esmo,cancer
myESMO,2020-09-19,esmo president eagerly await today presidential symposium cest compelling presentations lung renal cell access platform here,0.5994,positive,esmo,cancer
DrChoueiri,2020-09-12,getting ready outstanding program esmo president prof scientific chair many others plenaries well represented checkmate profound ipatential,0.8225,positive,esmo,cancer
tompowles1,2020-09-02,esmo virtual preceptorship metastatic bladder kidney cancer started really great renal cancer questions front line therapy focused immune therapy what line vegf therapy standard there very little prospective data,-0.1548,negative,esmo,cancer
FrommeyerSteven,2020-10-21,andrew davis division oncology washington university school medicine presents esmo breast cancer highlights tonight institutional perspectives cancer soss,-0.8689,negative,esmo,breast
BreastDocUK,2020-10-09,still massive variation breast cancer despite esmo guidance good narrative audio link below,-0.7786,negative,esmo,breast
boobstagramm,2020-09-24,immunomedics wows esmo with breast cancer data reveal pharmaphorum,-0.34,negative,esmo,breast
AntibioticNews,2020-09-22,esmo genentech shares data from phase triple negative breast cancer trials,-0.7845,negative,esmo,breast
boobstagramm,2020-09-22,esmo genentech shares data from phase triple negative breast cancer trials biospace,-0.7845,negative,esmo,breast
biospace,2020-09-22,esmo genentech shares data from phase triple negative breast cancer trials,-0.7845,negative,esmo,breast
AlcuriaRudolph,2020-09-21,esmo roche mixed results tecentriq triple negative breast cancer into question fiercepharma,-0.8442,negative,esmo,breast
AlcuriaRudolph,2020-09-21,esmo roche mixed results tecentriq triple negative breast cancer into question fiercepharma,-0.8442,negative,esmo,breast
BioCalifornia,2020-09-21,esmo genentech shares data from phase triple negative breast cancer trials,-0.7845,negative,esmo,breast
Corixis,2020-09-21,esmo genentech shares data from phase triple negative breast cancer trials,-0.7845,negative,esmo,breast
Biotechnology,2020-09-21,esmo genentech shares data from phase triple negative breast cancer trials,-0.7845,negative,esmo,breast
aspenbio,2020-09-21,esmo roche mixed results tecentriq triple negative breast cancer into question,-0.8442,negative,esmo,breast
pharm2market,2020-09-21,esmo roche mixed results tecentriq triple negative breast cancer into question,-0.8442,negative,esmo,breast
Dominic_Tyer,2020-09-21,immunomedics wows esmo with breast cancer data reveal,-0.34,negative,esmo,breast
Pharmashot,2020-09-21,roche presents data tecentriq triple negative breast cancer esmo virtual congress,-0.8442,negative,esmo,breast
MicrobiolCurRes,2020-09-21,immunomedics wows esmo with breast cancer data reveal,-0.34,negative,esmo,breast
cafepharma,2020-09-21,esmo roche mixed results tecentriq triple negative breast cancer into question,-0.8442,negative,esmo,breast
HelixBioPharma,2020-09-20,roche tecentriq currently only approved triple negative breast cancer posted mixed results hard treat disease this year esmo virtual congress rhhby,-0.6124,negative,esmo,breast
HelixBioPharma,2020-09-20,esmo roche mixed results tecentriq triple negative breast cancer into question rhhby,-0.8442,negative,esmo,breast
bergerb2,2020-09-20,presents data from multiple phase studies negative breast cancer esmo virtual congress swiss stock exchange,-0.8442,negative,esmo,breast
boobstagramm,2020-09-20,esmo roche mixed results tecentriq triple negative breast cancer into question fiercepharma,-0.8442,negative,esmo,breast
boobstagramm,2020-09-20,roche presents data from multiple phase studies tecentriq triple negative breast cancer esmo virtual congress globenewswire,-0.8442,negative,esmo,breast
PharmacDaily,2020-09-20,genentech presents data from multiple phase studies tecentriq triple negative breast cancer esmo virtual congress,-0.8442,negative,esmo,breast
PharmacDaily,2020-09-19,roche presents data from multiple phase studies tecentriq triple negative breast cancer esmo virtual congress,-0.8442,negative,esmo,breast
NewExpressNews,2020-09-19,esmo roche mixed results tecentriq triple negative breast cancer into question,-0.8442,negative,esmo,breast
EINBiotech,2020-09-19,genentech presents data from multiple phase studies tecentriq triple negative breast cancer esmo virtual congress,-0.8442,negative,esmo,breast
KillerStockCall,2020-09-19,rhhby stock genentech presents data from multiple phase studies tecentriq triple negative breast cancer esmo virtual congress,-0.8442,negative,esmo,breast
boobstagramm,2020-09-19,genentech presents data from multiple phase studies tecentriq triple negative breast cancer esmo virtual congress business wire,-0.8442,negative,esmo,breast
Stock_Market_Pr,2020-09-19,genentech presents data from multiple phase studies tecentriq triple negative breast cancer esmo virtual congress,-0.8442,negative,esmo,breast
Stock_Market_Pr,2020-09-19,roche presents data from multiple phase studies tecentriq triple negative breast cancer esmo virtual congress,-0.8442,negative,esmo,breast
otcdynamics,2020-09-19,rhhby genentech presents data from multiple phase studies tecentriq triple negative breast cancer esmo virtual congress,-0.8442,negative,esmo,breast
MazenzCom,2020-09-19,genentech presents data from multiple phase studies tecentriq triple negative breast cancer esmo virtual congress,-0.8442,negative,esmo,breast
seigomaeda,2020-09-19,esmo roche mixed results tecentriq triple negative breast cancer into question,-0.8442,negative,esmo,breast
equity_newswire,2020-09-19,genentech presents data from multiple phase studies tecentriq triple negative breast cancer esmo virtual congress,-0.8442,negative,esmo,breast
FlashAlert_me,2020-09-19,rhhby delayed issued press release september genentech presents data from multiple phase studies tecentriq triple negative breast cancer esmo virtual congress,-0.875,negative,esmo,breast
marktpirate1,2020-09-19,roche presents data from multiple phase studies tecentriq triple negative breast cancer esmo virtual congress,-0.8442,negative,esmo,breast
NewsFromBW,2020-09-19,genentech presents data from multiple phase studies tecentriq triple negative breast cancer esmo virtual congress,-0.8442,negative,esmo,breast
myESMO,2020-09-18,from esmo social media working group breast oncologists other physicians interest expect very important results number pivotal trials reporting their primary objective watch more here,0.6865,positive,esmo,breast
OncologyForum,2020-09-11,agree start talking about cancer again register class breast sessions with updates insights from asco esmo bctrcg workshop baso tumour surgical session cancer covid debate still open free,-0.6124,negative,esmo,breast
MEDtalksCH,2020-09-11,signed first esmo alps parallel virtual congress review discuss most important findings with swiss experts topics breast lung sarcoma others sign here,0.2716,positive,esmo,breast
OncologyForum,2020-09-08,hope some your members join virtual oncology forum free accredited class breast cancer programme esmo updates covid debate register september,0.4588,positive,esmo,breast
OncLiveSOSS,2020-09-06,previous episode mark pegram spotlighted notable data breast cancer that were presented during asco esmo breast virtual meetings,-0.6597,negative,esmo,breast
OncLive,2020-09-05,previous episode mark pegram spotlighted notable data breast cancer that were presented during asco esmo breast virtual meetings,-0.6597,negative,esmo,breast
OncologyForum,2020-09-04,hope join virtual oncology forum september free accredited class breast cancer educational sessions baso will deliver dynamic tumour surgical session esmo highlights much more register,0.6808,positive,esmo,breast
OncLive,2020-09-01,previous episode mark pegram spotlighted notable data breast cancer that were presented during asco esmo breast virtual meetings listen,-0.6597,negative,esmo,breast
OncologyForum,2020-08-30,meeting virtual free accredited your members most welcome class breast cancer sessions baso will deliver dynamic tumour session esmo highlights,0.5849,positive,esmo,breast
Azimkhan_2014,2020-08-28,very delighted abstracts accepted virtual important work indigenous women with breast cancer contribution towards well through studies excited esmo,0.7056,positive,esmo,breast
OncologyForum,2020-08-26,hope hcps join virtual oncology forum september free accredited class educational breast sessions baso will deliver dynamic tumour surgical session esmo highlights much more register,0.875,positive,esmo,breast
OncologyForum,2020-08-26,hope join virtual oncology forum september free accredited class educational breast cancer sessions baso will deliver dynamic tumour surgical session esmo highlights much more register,0.6808,positive,esmo,breast
OncologyForum,2020-08-26,hope join virtual oncology forum september free accredited class educational breast cancer sessions baso will deliver dynamic tumour surgical session esmo highlights register,0.6808,positive,esmo,breast
OncologyForum,2020-08-26,hope join virtual oncology forum september free accredited class educational breast cancer sessions baso deliver dynamic tumour surgical session esmo highlights register hcps only free,0.836,positive,esmo,breast
OncologyForum,2020-08-26,hope your breast cancer members join virtual oncology forum september free accredited class educational breast cancer sessions baso will deliver tumour surgical session esmo highlights register,-0.34,negative,esmo,breast
OncologyForum,2020-08-25,meeting virtual free accredited your members most welcome class breast cancer sessions baso will deliver dynamic tumour session esmo highlights,0.5849,positive,esmo,breast
OncologyForum,2020-08-21,hope join virtual oncology forum september free accredited esmo highlights much more leading breast expert speakers baso will deliver class tumour surgical session register,0.8126,positive,esmo,breast
prat_aleix,2020-08-20,correct intravenous administration interesting phase results breast cancer well presented esmo,-0.1531,negative,esmo,breast
OncologyForum,2020-08-20,still time register bctrcg workshop virtual oncology forum register class breast cancer speakers baso will also deliver tumour surgical session free covid esmo much more,-0.2732,negative,esmo,breast
OncologyForum,2020-09-19,will exhibiting virtual oncology forum hope register join meeting excellent bladder renal prostate programme class oncology expert speakers this week september incs esmo highlights,0.8316,positive,esmo,breast
OncologyForum,2020-09-12,rajesh nair joins class team speakers virtual oncology forum renal bladder sessions september free accredited esmo highlights covid cancer debate much more,-0.2732,negative,esmo,breast
OncologyForum,2020-09-12,delighted that simon crabb joins dynamic renal bladder team virtual oncology forum free september class leading expert speakers esmo highlights covid cancer debate jointly chaired prof choudhury,0.5859,positive,esmo,breast
OncLive,2020-10-21,breast cancer only hour away chaired cynthia register updates esmo breast cancer highlights,-0.8689,negative,breast,cancer
OUPMedicine,2020-10-21,pervasive global issue necessitates critical thinking initiative authors breast cancer global quality care broach some improvements cancer care centers this piece awareness,-0.5267,negative,breast,cancer
brunolarvol,2020-10-12,esmo ascent positions sacituzumab govitecan possible standard care previously treated metastatic triple negative breast cancer positioned,-0.7096,negative,breast,cancer
PracUpOnc,2020-10-12,esmo ascent positions sacituzumab govitecan possible standard care previously treated metastatic triple negative breast cancer,-0.7096,negative,breast,cancer
PracUpOnc,2020-10-10,esmo addition atezolizumab paclitaxel treatment triple negative breast cancer shows significant benefit,-0.6486,negative,breast,cancer
IBCResearch,2020-10-10,sacituzumab govitecan improves survival pretreated triple negative breast cancer,-0.743,negative,breast,cancer
MEDtalksCH,2020-10-06,international symbol breast cancer awareness breast cancer most commonly occurring cancer women insights click website,-0.9349,negative,breast,cancer
AgendaLifeSci,2020-10-03,esmo breast cancer drug transform prostate cancer treatment,-0.8689,negative,breast,cancer
DaniTernyila,2020-09-29,esmo congress came close several experts lung breast cancers shared their insights some most impactful abstracts from this year meeting,0.34,positive,breast,cancer
PredictiveOnc,2020-09-29,industry news conflicting esmo data raise questions about role inhibitors adjuvant breast cancer,-0.8442,negative,breast,cancer
myESMO,2020-09-29,esmo virtual preceptorship apply latest standard care management early locally metastatic breast cancer surgery radiation systemic therapy crucial role multidisciplinary care,0.25,positive,breast,cancer
PracUpOnc,2020-09-29,esmo recommendations from sara tolaney breast cancer,-0.6597,negative,breast,cancer
RICKLIN4TH,2020-09-28,neoadjuvant treatment future patients with breast cancer esmo open enables escalation surgery with improved,-0.3182,negative,breast,cancer
PTarantinoMD,2020-09-26,this been incredibly rich relevant news both early advanced treatment here personal selection breast cancer take home messages from esmo,0.1263,positive,breast,cancer
KristieRaupp,2020-09-24,helpful information breast cancer patients during covid make sure that people with cancer best care during covid pandemic esmo experts created their recommendations mammaprint blueprint,0.5719,positive,breast,cancer
SamFazeli8,2020-09-22,join solebury trout recap esmo data breast lung cancer,-0.4939,negative,breast,cancer
Engelsgjerd,2020-09-22,please join bloomberg intelligence esmo recap webinar friday joined three experts will into latest breast lung cancer datasets register here,0.296,positive,breast,cancer
OncologyNewsAus,2020-09-22,oncology news update esmo sacituzumab govitecan hziy extends survival phase ascent study metastatic triple negative breast cancer been published oncology news australia,-0.8225,negative,breast,cancer
darylmox,2020-09-22,esmo breast cancer drug transform prostate cancer treatment,-0.8689,negative,breast,cancer
OncJournal,2020-09-22,esmo breast cancer drug transform prostate cancer treatment,-0.8689,negative,breast,cancer
AlcuriaRudolph,2020-09-21,esmo novartis parses long awaited survival data breast cancer blockbuster hopeful piqray fiercepharma,0.4019,positive,breast,cancer
PharmaTopNews1,2020-09-21,esmo novartis parses long awaited survival data breast cancer blockbuster hopeful piqray fiercepharma,0.4019,positive,breast,cancer
healthcarejon,2020-09-21,piqray faslodex combo extends survival advanced breast cancer esmo,-0.4404,negative,breast,cancer
sciencecodex,2020-09-21,esmo breast cancer drug transform prostate cancer treatment,-0.8689,negative,breast,cancer
SciSolutions,2020-09-21,esmo breast cancer drug transform prostate cancer treatment,-0.8689,negative,breast,cancer
7thSpaceCom,2020-09-21,news esmo breast cancer drug transform prostate cancer treatment,-0.8689,negative,breast,cancer
Science28960840,2020-09-21,esmo breast cancer drug transform prostate cancer treatment,-0.8689,negative,breast,cancer
ShootForLife,2020-09-21,esmo breast cancer drug transform prostate cancer treatment,-0.8689,negative,breast,cancer
boobstagramm,2020-09-20,esmo breast cancer drug transform prostate cancer treatment eurekalert,-0.8689,negative,breast,cancer
NovartisCancer,2020-09-20,will presenting data treatment advanced breast cancer patients with endocrine resistance visit esmo portal learn more,-0.5267,negative,breast,cancer
NewsBlogged,2020-09-20,news esmo breast cancer drug transform prostate cancer treatment,-0.8689,negative,breast,cancer
cancer_network,2020-09-20,esmo breast cancer drug transform prostate cancer treatment,-0.8689,negative,breast,cancer
thedextazlab,2020-09-20,esmo breast cancer drug transform prostate cancer treatment,-0.8689,negative,breast,cancer
quant_data,2020-09-20,novartis announced saturday esmo piqray data show survival benefit patients with advanced breast cancer with mutation related tickers,-0.1027,negative,breast,cancer
ESMO_Open,2020-09-20,accessed article open shall treat early triple negative breast cancer from current standard upcoming immuno molecular strategies,-0.7506,negative,breast,cancer
PharmaCrowd,2020-09-20,esmo novartis parses long awaited survival data breast cancer blockbuster hopeful piqray,0.4019,positive,breast,cancer
MedexpertC,2020-09-20,treatment option hard treat triple negative breast cancer presented european cancer meeting esmo very active will improve survival,-0.7222,negative,breast,cancer
cafepharma,2020-09-20,esmo novartis parses long awaited survival data breast cancer blockbuster hopeful piqray,0.4019,positive,breast,cancer
NewExpressNews,2020-09-20,esmo novartis parses long awaited survival data breast cancer blockbuster hopeful piqray,0.4019,positive,breast,cancer
analystlandnews,2020-09-19,esmo novartis parses long awaited survival data breast cancer blockbuster hopeful piqray,0.4019,positive,breast,cancer
boobstagramm,2020-09-19,esmo novartis parses long awaited survival data breast cancer blockbuster hopeful piqray fiercepharma,0.4019,positive,breast,cancer
seigomaeda,2020-09-19,esmo novartis parses long awaited survival data breast cancer blockbuster hopeful piqray,0.4019,positive,breast,cancer
DrFelipeAdes,2020-09-19,follow conferences since esmo breast when months months,0.0,neutral,breast,cancer
biotechkid2,2020-09-13,wonder there some surprisingly good data esmo beyond ascent breast given myelosuppression with trodelvy will challenging show dramatic benefit with chemo adjuvant settings,0.8271,positive,breast,cancer
VukovicPetra,2020-09-08,supplement management treatment adapted recommendations lung cancer colorectal cancer breast cancer pancreatic cancer renal cell carcinoma gynecological malignancies,-0.9618,negative,breast,cancer
CancerDirectory,2020-08-26,novel biomarkers predict benefit with immunotherapy metastatic breast cancer esmo press release,-0.0258,neutral,breast,cancer
ChandlerHParkMD,2020-10-05,thank doing doximity discussion with after esmo meeting renal cell cancer update physicians loved talking about most current data treatment recommendations patients,0.25,positive,breast,cancer
rothermundtc,2020-08-30,impact covid pandemic treatment patterns metastatic clear cell renal cell carcinoma esmo open,0.3818,positive,breast,cancer
EiocOncology,2020-10-16,excited eioc virtual congress breast cancer session going live mins forget join time join virtual congress here,-0.128,negative,breast,therapy
EiocOncology,2020-10-05,view breast program here care congress,0.4939,positive,breast,therapy
Dr_RShatsky,2020-09-23,esmo always feels like warmup like teaser exciting breakthroughs breast cancer world possible drug approvals that give patients more options time always look forward december,0.296,positive,breast,therapy
ttccgroup,2020-09-21,esmo virtual congress findings breast head neck cancers asco post,0.0,neutral,breast,therapy
GaiaGriguolo,2020-09-19,rushing from breast cancer session presidential session just quick stop photo this feels like esmo,-0.6249,negative,breast,therapy
john_bresnahan,2020-09-10,will nice data from pallas randomized phase trial adjuvant palbociclib with endocrine therapy versus endocrine therapy alone early breast cancer recall line read really them hard,-0.6461,negative,breast,therapy
MM_Oncology,2020-10-09,another trial tinivo that covered last year esmo also published click below report this study nivolumab tivozanib metastatic,0.0,neutral,breast,therapy
Dr_Ivanoncologo,2020-10-04,post esmo news thanks excellent session,0.765,positive,breast,therapy
sohecsas,2020-10-02,sohec invita asistir curso post esmo virtual cancer renal carcinoma urotelial este bado octubre interesado favor escr benos correo siceventos enviaremos datos acceso conferencia,-0.4019,negative,breast,therapy
AlcuriaRudolph,2020-09-21,esmo trodelvy breast bladder cancer data show gilead going immunomedics fiercepharma,-0.6597,negative,esmo,breast
BOPACommittee,2020-09-21,with wrapped today hope enjoyed esmo updates over last days main headliners this year related breast lung urological cancers bopa virtual symposium october long,0.7351,positive,esmo,breast
pharm2market,2020-09-21,esmo trodelvy breast bladder cancer data show gilead going immunomedics,-0.6597,negative,esmo,breast
aspenbio,2020-09-21,esmo trodelvy breast bladder cancer data show gilead going immunomedics,-0.6597,negative,esmo,breast
NovartisNews,2020-09-21,novartis announces advanced breast cancer treatment receives highest rating inhibitor esmo magnitude clinical benefit scale,-0.1779,negative,esmo,breast
boobstagramm,2020-09-21,esmo trodelvy breast bladder cancer data show gilead going immunomedics fiercepharma,-0.6597,negative,esmo,breast
SuriyaSubraman,2020-09-19,esmo trodelvy breast bladder cancer data show gilead going immunomedics sets cancer data from immunomedics first class antibody drug conjugate trodelvy offer glimpse into gilead paid such,-0.8689,negative,esmo,breast
mednetnews,2020-09-19,esmo trodelvy breast bladder cancer data show gilead going immunomedics,-0.6597,negative,esmo,breast
MarcJacksonLA,2020-09-19,immu gild esmo trodelvy breast bladder cancer data show gilead going immunomedics,-0.6597,negative,esmo,breast
NewExpressNews,2020-09-19,esmo trodelvy breast bladder cancer data show gilead going immunomedics,-0.6597,negative,esmo,breast
seigomaeda,2020-09-19,esmo trodelvy breast bladder cancer data show gilead going immunomedics,-0.6597,negative,esmo,breast
_SOLTI,2020-09-19,esmo virtual congress starting come check poster ipather phase study ipatasertib anti therapy positive advanced breast cancer with camutation more info,-0.2732,negative,esmo,breast
_SOLTI,2020-09-18,ready esmo virtual congress come check poster ipather phase study ipatasertib anti therapy positive advanced breast cancer with camutation more info,0.1027,positive,esmo,breast
BoycottTrumpBus,2020-09-10,immu trodelvy esmo phase study antibody drug conjugate sacituzumab govitecan combination with parp inhibitor talazoparib metastatic triple negative breast cancer trophy cohort pembro,-0.8555,negative,esmo,breast
kidneycancers,2020-10-17,takeaways from esmo immunotherapy renal cell carcinoma,0.0,neutral,cell,renal
sogug1,2020-10-16,disponible revisi relevante ncer renal esmo feliz semana,0.0,neutral,cell,renal
PracUpOnc,2020-10-03,esmo nivolumab plus cabozantinib outperforms sunitinib advanced renal cell carcinoma,0.25,positive,cell,renal
PracUpOnc,2020-10-01,esmo recommendations from eric jonasch renal cell carcinoma,0.0,neutral,cell,renal
PracUpOnc,2020-09-30,esmo recommendations from eric jonasch renal cell carcinoma,0.0,neutral,cell,renal
IKCCorg,2020-09-20,esmo highlights hippel lind syndrome occurs because hereditary inactivating genomic alterations gene resulting higher risk developing renal cell carcinoma,-0.2732,negative,cell,renal
quant_data,2020-09-20,bristol myers squibb exelixis announced saturday esmo opdivo combination with cabometyx demonstrates significant survival benefits patients with advanced renal cell carcinoma pivotal phase checkmate trial related tickers exel,0.6597,positive,cell,renal
MazenzCom,2020-09-20,esmo cabometyx cabozantinib combination with opdivo nivolumab demonstrates significant survival benefits patients with advanced renal cell carcinoma pivotal phase checkmate trial,0.6597,positive,cell,renal
PharmacDaily,2020-09-20,esmo cabometyx cabozantinib combination with opdivo nivolumab demonstrates significant survival benefits patients with advanced renal cell carcinoma pivotal phase checkmate trial,0.6597,positive,cell,renal
Stock_Market_Pr,2020-09-19,esmo cabometyx cabozantinib combination with opdivo nivolumab demonstrates significant survival benefits patients with advanced renal cell carcinoma pivotal phase checkmate trial,0.6597,positive,cell,renal
otcdynamics,2020-09-19,ipsey esmo cabometyx cabozantinib combination with opdivo nivolumab demonstrates significant survival benefits patients with advanced renal cell carcinoma pivotal phase checkmate,0.6597,positive,cell,renal
equity_newswire,2020-09-19,esmo cabometyx cabozantinib combination with opdivo nivolumab demonstrates significant survival benefits patients with advanced renal cell carcinoma pivotal phase checkmate trial,0.6597,positive,cell,renal
NewsFromBW,2020-09-19,esmo cabometyx cabozantinib combination with opdivo nivolumab demonstrates significant survival benefits patients with advanced renal cell carcinoma pivotal phase checkmate trial,0.6597,positive,cell,renal
IKCCorg,2020-09-19,esmo recommendations from ikcc board director eric jonasch renal cell carcinoma,0.0,neutral,cell,renal
Matulienko,2020-09-17,exel esmo presentation this weekend stellar data bilions sales year just renal said data good enough bring benefit literally patients with advanced untreated kidney cancer,0.3612,positive,cell,renal
ej23ny,2020-09-13,exel phase checkmate cabo opdivo will presented next week abstract selected best abstract conference abbv bmrn vrtx tsla appl amzon googl alxo,0.6369,positive,cell,renal
